Who We Are
VertigoDx is a medical technology company focused on practical tools for vestibular evaluation in clinics, emergency care settings, and rehabilitation environments.
Point-of-Care Vestibular Testing
Vestibular assessment support,
in the palm of your hand.
SmartVertigo™ is a portable, smartphone-based system designed to help clinicians record, review, and document eye movements during positional vestibular testing.
RecordReviewDocument
510(k) Submitted — Under FDA ReviewPatent Pending — Worldwide PCTBuilt with cliniciansPortable · Smartphone-based
About VertigoDx
Portable technology for clinician-led vestibular assessment.
VertigoDx, Inc. develops SmartVertigo™ — a smartphone-based headset and mobile application intended to capture close-up eye-movement video during positional vestibular testing.
Clinician reviewDocumentationPatient educationContinuity of care
Clinical interpretation, diagnosis, and treatment decisions remain the responsibility of the licensed healthcare professional.
What We Do
SmartVertigo™ helps clinicians visualize, record, replay, and document eye movements observed during standardized positional testing.
Patent Status
SmartVertigo™ is patent pending, including a worldwide PCT patent application and related provisional patent filings.
How It Works
Three steps to point-of-care positional testing.
Portable eye-movement recording and playback to support clinician review and documentation at the point of care.
Fit the Headset
Place the SmartVertigo™ headset on the patient. Built-in optics block ambient light — no darkroom needed.
Run the Exam
Perform standardized positional tests used by clinicians when evaluating suspected BPPV and related vestibular complaints.
Review the Results
Eye-movement recordings are available immediately for clinician review, playback, and documentation.
Point-of-Care Recording
Close-up eye-movement video, captured during positional testing.
Recorded through the SmartVertigo™ headset for clinician review, playback, and documentation.
Leadership
Who we are and what we do.
Dr. Paul Louis, MD
Chief Executive OfficerEmergency medicine physician who joined VertigoDx as Chief Executive Officer to help advance point-of-care vestibular assessment technology.
Trevor Meyerowitz, PT
Chief Medical OfficerPhysical Therapist for over 36 years specializing in vertigo and vestibular rehabilitation.
Stephen Meyerowitz
Chief Technology OfficerEngineering lead responsible for the SmartVertigo™ hardware platform, mobile application, and product development.
Alan Keschner
Chief Financial OfficerFinancial executive supporting healthcare operations, business planning, and medical device company development.
Get in Touch
Request a demo.
Fill in your details and a member of our team will be in touch.
Patent & FDA Status
Patent Pending — Worldwide PCTUnder FDA ReviewNot Yet FDA Cleared
SmartVertigo™ is patent pending, including a worldwide PCT patent application and related provisional patent filings.
SmartVertigo™ is currently under review by the U.S. Food and Drug Administration (FDA) and has not yet received FDA clearance. SmartVertigo™ is intended for use only where permitted by applicable laws and regulations until such clearance is obtained.